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Measles virus induces an acute disease with rash and fever. Despite ongoing vaccination and elimination campaigns, the measles
virus still sustains long-lasting transmission chains in Europe. Here we report the complete genome sequence of a wild-type
measles virus isolated from a patient in Munich (MVi/Muenchen.DEU/19.13[D8]) during a German measles outbreak in 2013.
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Infections caused by measles virus (MV), the prototype of theMorbillivirus genus of the Paramyxoviridae family, remain a se-
rious threat to human health worldwide. In 2011, approximately
160,000 deaths were caused by measles, although MV elimination
is sought globally (1–3). Infection with MV is typically accompa-
nied by transient immune suppression abetting secondary infec-
tions. MV itself can cause encephalitis and rare severe sequelae,
including measles inclusion-body encephalitis (MIBE) and sub-
acute sclerosing panencephalitis (SSPE), resulting inevitably in
the death of the patient (4).
MV wild-type (wt) infection chains have been recently ob-
served all over Europe (5, 6). In 2013, 704 measles cases were
reported in Upper Bavaria and 306 in Munich. MV was isolated
from a throat swab from a patient with typical clinical symptoms
using Vero-hSLAM cells (7). The virus was cultivated for 48 h
until syncytium formation was visible. Whole-cell RNA was ex-
tracted from infected Vero-hSLAM cells by using the Qiagen
RNeasy minikit (Quiagen), and 100 ng was used to prepare a
strand-specific RNA-Seq library kit (NuGEN Encore complete
RNA-Seq library system; NuGEN, Inc.) following the manufac-
turer’s instruction. The resulting library was sequenced on an Il-
lumina MiSeq instrument in paired-end mode with a read length
of 250 nucleotides (nt).
Sequence reads were aligned at first to the sequence of the MV
vaccine strain Schwarz (GenBank accession number AF266291.1)
and for further refinement to that of a closely related MV isolate
(MVi/Texas.USA/4.07, genotype D8; GenBank accession number
JN635407.1). Only reads mapping to these MV strains were used
for genome assembly using the de novo assembler Velvet (8). Cov-
erage for an average nucleotide in the N gene was approximately
400 reads, and for the L gene, 50 reads. Nucleotides with a low
coverage within the L gene and H-L gene border were sequenced
using conventional reverse transcription and sequencing using
specific primers (GATC, Constance, Germany). The nucleotide
sequences of the 3= leader and 5= trailer regions were determined
by 5= rapid amplification of cDNA ends (5=-RACE) using specific
primers binding in the leader and trailer sequences and terminal
deoxynucleotidyl transferase (TdT) for addition of a poly(A) tail.
PCR was carried out using a dT(18) primer with an EcoRI site, and
the resulting DNA fragments were cloned into pCR3 vectors for
sequencing of multiple clones. The presented full genome there-
fore represents an assembly of sequences obtained by the three
techniques described above.
Genotyping according to the WHO protocol (9) using the
450 nucleotides of the 3=-end of the N gene classified the pres-
ent wt strain as a D8 genotype, subtype Frankfurt-Main (MVs/
Frankfurt Main.DEU/17.11-variant). The genome of MVi/
Muenchen.DEU/19.13 follows the canonical 3=-N-P/V/C-M-F-
H-L-5= gene arrangement and comprises 15,984 nucleotides
and therefore obeys the rule of six (10, 11). It shares 99% iden-
tity with the complete genome of the MVi/Texas.USA/4.07 wt
isolate and 96.55% identity with that of the MV strain Schwarz.
As is typically seen for wt versus vaccine strain comparisons,
the C protein sequence contains a fully conserved nuclear lo-
calization sequence (NLS) (12), while the H protein lacks the
typical N481Y or S546G mutation required for CD46 binding
(13, 14). MVi/Muenchen.DEU/19.13 therefore represents a
typical wt MV circulating in Germany.
Nucleotide sequence accession number. The complete ge-
nome sequence of the MVi/Muenchen.DEU/19.13[D8] isolate is
available at GenBank under the accession number KJ410048.
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